 | • レポートコード：MRC2312MG15322 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のオルガノイドバイオバンク市場規模と予測を収録しています。・世界のオルガノイドバイオバンク市場：売上、2018年-2023年、2024年-2029年 ・世界のオルガノイドバイオバンク市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のオルガノイドバイオバンク市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「組織由来オルガノイド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 オルガノイドバイオバンクのグローバル主要企業は、FRANKFURT CANCER INSTITUTE、 Merck、 Crown Bioscience、 HUB Organoids、 Cancer Research UK Convergence Science Centre、 Thermo Fisher Scientific、 Corning、 STEMCELL Technologies、 Lonza、 Prellis Biologics、 Amsbio、 Cellesce、 DefiniGEN、 3Dnamics Inc.、 Organoid Therapeutics、 InSphero、 AIVITA Biomedical、 JangoBioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、オルガノイドバイオバンクのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のオルガノイドバイオバンク市場：タイプ別、2018年-2023年、2024年-2029年 世界のオルガノイドバイオバンク市場：タイプ別市場シェア、2022年 ・組織由来オルガノイド、多能性幹細胞由来オルガノイド 世界のオルガノイドバイオバンク市場：用途別、2018年-2023年、2024年-2029年 世界のオルガノイドバイオバンク市場：用途別市場シェア、2022年 ・バイオ医薬品企業、受託研究機関、学術研究機関 世界のオルガノイドバイオバンク市場：地域・国別、2018年-2023年、2024年-2029年 世界のオルガノイドバイオバンク市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるオルガノイドバイオバンクのグローバル売上、2018年-2023年 ・主要企業におけるオルガノイドバイオバンクのグローバル売上シェア、2022年 ・主要企業におけるオルガノイドバイオバンクのグローバル販売量、2018年-2023年 ・主要企業におけるオルガノイドバイオバンクのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 FRANKFURT CANCER INSTITUTE、 Merck、 Crown Bioscience、 HUB Organoids、 Cancer Research UK Convergence Science Centre、 Thermo Fisher Scientific、 Corning、 STEMCELL Technologies、 Lonza、 Prellis Biologics、 Amsbio、 Cellesce、 DefiniGEN、 3Dnamics Inc.、 Organoid Therapeutics、 InSphero、 AIVITA Biomedical、 JangoBio ************************************************************* ・調査・分析レポートの概要 オルガノイドバイオバンク市場の定義 市場セグメント 世界のオルガノイドバイオバンク市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のオルガノイドバイオバンク市場規模 世界のオルガノイドバイオバンク市場規模：2022年 VS 2029年 世界のオルガノイドバイオバンク市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのオルガノイドバイオバンクの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のオルガノイドバイオバンク製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：組織由来オルガノイド、多能性幹細胞由来オルガノイド オルガノイドバイオバンクのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：バイオ医薬品企業、受託研究機関、学術研究機関 オルガノイドバイオバンクの用途別グローバル売上・予測 ・地域別市場分析 地域別オルガノイドバイオバンク市場規模 2022年と2029年 地域別オルガノイドバイオバンク売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） FRANKFURT CANCER INSTITUTE、 Merck、 Crown Bioscience、 HUB Organoids、 Cancer Research UK Convergence Science Centre、 Thermo Fisher Scientific、 Corning、 STEMCELL Technologies、 Lonza、 Prellis Biologics、 Amsbio、 Cellesce、 DefiniGEN、 3Dnamics Inc.、 Organoid Therapeutics、 InSphero、 AIVITA Biomedical、 JangoBio ... |
This research report provides a comprehensive analysis of the Organoid Biobank market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Organoid Biobank market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Organoid Biobank, challenges faced by the industry, and potential opportunities for market players.
The global Organoid Biobank market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Organoid Biobank market presents opportunities for various stakeholders, including Biopharmaceutical Companies, Contract Research Organizations. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Organoid Biobank market. Additionally, the growing consumer demand present avenues for market expansion.
The global Organoid Biobank market was valued at US$ 114.1 million in 2022 and is projected to reach US$ 386.8 million by 2029, at a CAGR of 19.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Key Features:
The research report on the Organoid Biobank market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Organoid Biobank market.
Market Overview: The report provides a comprehensive overview of the Organoid Biobank market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Organoid Biobank market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Organoid Biobank market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Organoid Biobank market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Organoid Biobank market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Organoid Biobank market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Organoid Biobank market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Organoid Biobank, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Organoid Biobank market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Organoid Biobank market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Market segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Global Organoid Biobank Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Organoid Biobank, market overview.
Chapter 2: Global Organoid Biobank market size in revenue.
Chapter 3: Detailed analysis of Organoid Biobank company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organoid Biobank in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Organoid Biobank Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Organoid Biobank Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Organoid Biobank Overall Market Size
2.1 Global Organoid Biobank Market Size: 2022 VS 2029
2.2 Global Organoid Biobank Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Organoid Biobank Players in Global Market
3.2 Top Global Organoid Biobank Companies Ranked by Revenue
3.3 Global Organoid Biobank Revenue by Companies
3.4 Top 3 and Top 5 Organoid Biobank Companies in Global Market, by Revenue in 2022
3.5 Global Companies Organoid Biobank Product Type
3.6 Tier 1, Tier 2 and Tier 3 Organoid Biobank Players in Global Market
3.6.1 List of Global Tier 1 Organoid Biobank Companies
3.6.2 List of Global Tier 2 and Tier 3 Organoid Biobank Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Organoid Biobank Market Size Markets, 2022 & 2029
4.1.2 Tissue Derived Organoids
4.1.3 Pluripotent Stem Cell-derived Organoids
4.2 By Type – Global Organoid Biobank Revenue & Forecasts
4.2.1 By Type – Global Organoid Biobank Revenue, 2018-2023
4.2.2 By Type – Global Organoid Biobank Revenue, 2024-2029
4.2.3 By Type – Global Organoid Biobank Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Organoid Biobank Market Size, 2022 & 2029
5.1.2 Biopharmaceutical Companies
5.1.3 Contract Research Organizations
5.1.4 Academics and Research Institutes
5.2 By Application – Global Organoid Biobank Revenue & Forecasts
5.2.1 By Application – Global Organoid Biobank Revenue, 2018-2023
5.2.2 By Application – Global Organoid Biobank Revenue, 2024-2029
5.2.3 By Application – Global Organoid Biobank Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Organoid Biobank Market Size, 2022 & 2029
6.2 By Region – Global Organoid Biobank Revenue & Forecasts
6.2.1 By Region – Global Organoid Biobank Revenue, 2018-2023
6.2.2 By Region – Global Organoid Biobank Revenue, 2024-2029
6.2.3 By Region – Global Organoid Biobank Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Organoid Biobank Revenue, 2018-2029
6.3.2 US Organoid Biobank Market Size, 2018-2029
6.3.3 Canada Organoid Biobank Market Size, 2018-2029
6.3.4 Mexico Organoid Biobank Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Organoid Biobank Revenue, 2018-2029
6.4.2 Germany Organoid Biobank Market Size, 2018-2029
6.4.3 France Organoid Biobank Market Size, 2018-2029
6.4.4 U.K. Organoid Biobank Market Size, 2018-2029
6.4.5 Italy Organoid Biobank Market Size, 2018-2029
6.4.6 Russia Organoid Biobank Market Size, 2018-2029
6.4.7 Nordic Countries Organoid Biobank Market Size, 2018-2029
6.4.8 Benelux Organoid Biobank Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Organoid Biobank Revenue, 2018-2029
6.5.2 China Organoid Biobank Market Size, 2018-2029
6.5.3 Japan Organoid Biobank Market Size, 2018-2029
6.5.4 South Korea Organoid Biobank Market Size, 2018-2029
6.5.5 Southeast Asia Organoid Biobank Market Size, 2018-2029
6.5.6 India Organoid Biobank Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Organoid Biobank Revenue, 2018-2029
6.6.2 Brazil Organoid Biobank Market Size, 2018-2029
6.6.3 Argentina Organoid Biobank Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Organoid Biobank Revenue, 2018-2029
6.7.2 Turkey Organoid Biobank Market Size, 2018-2029
6.7.3 Israel Organoid Biobank Market Size, 2018-2029
6.7.4 Saudi Arabia Organoid Biobank Market Size, 2018-2029
6.7.5 UAE Organoid Biobank Market Size, 2018-2029
7 Organoid Biobank Companies Profiles
7.1 FRANKFURT CANCER INSTITUTE
7.1.1 FRANKFURT CANCER INSTITUTE Company Summary
7.1.2 FRANKFURT CANCER INSTITUTE Business Overview
7.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Major Product Offerings
7.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue in Global Market (2018-2023)
7.1.5 FRANKFURT CANCER INSTITUTE Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Organoid Biobank Major Product Offerings
7.2.4 Merck Organoid Biobank Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Crown Bioscience
7.3.1 Crown Bioscience Company Summary
7.3.2 Crown Bioscience Business Overview
7.3.3 Crown Bioscience Organoid Biobank Major Product Offerings
7.3.4 Crown Bioscience Organoid Biobank Revenue in Global Market (2018-2023)
7.3.5 Crown Bioscience Key News & Latest Developments
7.4 HUB Organoids
7.4.1 HUB Organoids Company Summary
7.4.2 HUB Organoids Business Overview
7.4.3 HUB Organoids Organoid Biobank Major Product Offerings
7.4.4 HUB Organoids Organoid Biobank Revenue in Global Market (2018-2023)
7.4.5 HUB Organoids Key News & Latest Developments
7.5 Cancer Research UK Convergence Science Centre
7.5.1 Cancer Research UK Convergence Science Centre Company Summary
7.5.2 Cancer Research UK Convergence Science Centre Business Overview
7.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Major Product Offerings
7.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue in Global Market (2018-2023)
7.5.5 Cancer Research UK Convergence Science Centre Key News & Latest Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Organoid Biobank Major Product Offerings
7.6.4 Thermo Fisher Scientific Organoid Biobank Revenue in Global Market (2018-2023)
7.6.5 Thermo Fisher Scientific Key News & Latest Developments
7.7 Corning
7.7.1 Corning Company Summary
7.7.2 Corning Business Overview
7.7.3 Corning Organoid Biobank Major Product Offerings
7.7.4 Corning Organoid Biobank Revenue in Global Market (2018-2023)
7.7.5 Corning Key News & Latest Developments
7.8 STEMCELL Technologies
7.8.1 STEMCELL Technologies Company Summary
7.8.2 STEMCELL Technologies Business Overview
7.8.3 STEMCELL Technologies Organoid Biobank Major Product Offerings
7.8.4 STEMCELL Technologies Organoid Biobank Revenue in Global Market (2018-2023)
7.8.5 STEMCELL Technologies Key News & Latest Developments
7.9 Lonza
7.9.1 Lonza Company Summary
7.9.2 Lonza Business Overview
7.9.3 Lonza Organoid Biobank Major Product Offerings
7.9.4 Lonza Organoid Biobank Revenue in Global Market (2018-2023)
7.9.5 Lonza Key News & Latest Developments
7.10 Prellis Biologics
7.10.1 Prellis Biologics Company Summary
7.10.2 Prellis Biologics Business Overview
7.10.3 Prellis Biologics Organoid Biobank Major Product Offerings
7.10.4 Prellis Biologics Organoid Biobank Revenue in Global Market (2018-2023)
7.10.5 Prellis Biologics Key News & Latest Developments
7.11 Amsbio
7.11.1 Amsbio Company Summary
7.11.2 Amsbio Business Overview
7.11.3 Amsbio Organoid Biobank Major Product Offerings
7.11.4 Amsbio Organoid Biobank Revenue in Global Market (2018-2023)
7.11.5 Amsbio Key News & Latest Developments
7.12 Cellesce
7.12.1 Cellesce Company Summary
7.12.2 Cellesce Business Overview
7.12.3 Cellesce Organoid Biobank Major Product Offerings
7.12.4 Cellesce Organoid Biobank Revenue in Global Market (2018-2023)
7.12.5 Cellesce Key News & Latest Developments
7.13 DefiniGEN
7.13.1 DefiniGEN Company Summary
7.13.2 DefiniGEN Business Overview
7.13.3 DefiniGEN Organoid Biobank Major Product Offerings
7.13.4 DefiniGEN Organoid Biobank Revenue in Global Market (2018-2023)
7.13.5 DefiniGEN Key News & Latest Developments
7.14 3Dnamics Inc.
7.14.1 3Dnamics Inc. Company Summary
7.14.2 3Dnamics Inc. Business Overview
7.14.3 3Dnamics Inc. Organoid Biobank Major Product Offerings
7.14.4 3Dnamics Inc. Organoid Biobank Revenue in Global Market (2018-2023)
7.14.5 3Dnamics Inc. Key News & Latest Developments
7.15 Organoid Therapeutics
7.15.1 Organoid Therapeutics Company Summary
7.15.2 Organoid Therapeutics Business Overview
7.15.3 Organoid Therapeutics Organoid Biobank Major Product Offerings
7.15.4 Organoid Therapeutics Organoid Biobank Revenue in Global Market (2018-2023)
7.15.5 Organoid Therapeutics Key News & Latest Developments
7.16 InSphero
7.16.1 InSphero Company Summary
7.16.2 InSphero Business Overview
7.16.3 InSphero Organoid Biobank Major Product Offerings
7.16.4 InSphero Organoid Biobank Revenue in Global Market (2018-2023)
7.16.5 InSphero Key News & Latest Developments
7.17 AIVITA Biomedical
7.17.1 AIVITA Biomedical Company Summary
7.17.2 AIVITA Biomedical Business Overview
7.17.3 AIVITA Biomedical Organoid Biobank Major Product Offerings
7.17.4 AIVITA Biomedical Organoid Biobank Revenue in Global Market (2018-2023)
7.17.5 AIVITA Biomedical Key News & Latest Developments
7.18 JangoBio
7.18.1 JangoBio Company Summary
7.18.2 JangoBio Business Overview
7.18.3 JangoBio Organoid Biobank Major Product Offerings
7.18.4 JangoBio Organoid Biobank Revenue in Global Market (2018-2023)
7.18.5 JangoBio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer